NO20035572L - Fremgangsmate til fremstilling av piperidinderivatet fexofenadin - Google Patents

Fremgangsmate til fremstilling av piperidinderivatet fexofenadin

Info

Publication number
NO20035572L
NO20035572L NO20035572A NO20035572A NO20035572L NO 20035572 L NO20035572 L NO 20035572L NO 20035572 A NO20035572 A NO 20035572A NO 20035572 A NO20035572 A NO 20035572A NO 20035572 L NO20035572 L NO 20035572L
Authority
NO
Norway
Prior art keywords
fexofenadine
preparing
piperidine derivative
piperidine
derivative
Prior art date
Application number
NO20035572A
Other languages
English (en)
Norwegian (no)
Other versions
NO20035572D0 (no
Inventor
Collin Schroeder
Ryan Huddleston
Richard Charles
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20035572D0 publication Critical patent/NO20035572D0/no
Publication of NO20035572L publication Critical patent/NO20035572L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20035572A 2001-06-15 2003-12-12 Fremgangsmate til fremstilling av piperidinderivatet fexofenadin NO20035572L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29839701P 2001-06-15 2001-06-15
PCT/EP2002/006424 WO2002102776A1 (en) 2001-06-15 2002-06-12 Process for the production of the piperidine derivative fexofenadine

Publications (2)

Publication Number Publication Date
NO20035572D0 NO20035572D0 (no) 2003-12-12
NO20035572L true NO20035572L (no) 2004-02-16

Family

ID=23150325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035572A NO20035572L (no) 2001-06-15 2003-12-12 Fremgangsmate til fremstilling av piperidinderivatet fexofenadin

Country Status (23)

Country Link
US (2) US6743941B2 (is)
EP (1) EP1401816B1 (is)
JP (1) JP4344230B2 (is)
KR (1) KR100903285B1 (is)
CN (1) CN1229347C (is)
AR (1) AR037005A1 (is)
AT (1) ATE386021T1 (is)
AU (1) AU2002320847B2 (is)
BR (1) BR0210410A (is)
CA (1) CA2450313C (is)
DE (1) DE60225008T2 (is)
DK (1) DK1401816T3 (is)
ES (1) ES2298384T3 (is)
HK (1) HK1063795A1 (is)
HU (1) HUP0401125A2 (is)
IL (2) IL159304A0 (is)
MX (1) MXPA03010960A (is)
NO (1) NO20035572L (is)
NZ (1) NZ530153A (is)
PL (1) PL364369A1 (is)
PT (1) PT1401816E (is)
WO (1) WO2002102776A1 (is)
ZA (1) ZA200308697B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
CN100453522C (zh) * 2005-01-26 2009-01-21 中国科学技术大学 4-[4-(1-乙氧基酰基-1-甲基乙基苯)]-4-氧代丁酸的制备方法
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061491A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
CN102070490B (zh) * 2009-11-21 2014-07-30 浙江华海药业股份有限公司 一种非索非那定中间体2-(4-(4-羟基丁酰基)苯基)-2-甲基丙氰的制备方法
CN102070570A (zh) * 2009-11-21 2011-05-25 浙江华海药业股份有限公司 一种非索非那定中间体2-甲基-2(4-(2-氧代四氢呋喃-3-羰基)苯基)丙氰及其盐的制备方法
BR112017026159A2 (pt) 2015-06-15 2018-08-14 Asana Biosciences, Llc inibidores heterocíclicos de erk1 e erk2 e seu uso no tratamento de câncer
CN104876853B (zh) * 2015-06-17 2017-06-16 苏州卫生职业技术学院 盐酸非索非那定的合成方法
EP3365327B1 (en) 2015-10-22 2019-11-20 Sanofi-Aventis Deutschland GmbH Process for the preparation of fexofenadine and of intermediates used therein
AU2020375720A1 (en) 2019-10-28 2022-05-19 Asana Biosciences, Llc Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of ERK1 and ERK2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2946809A1 (de) * 1979-11-20 1981-06-11 A. Nattermann & Cie GmbH, 5000 Köln 4-phenyl-4-oxo-buttersaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
EP0347123A3 (en) 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties
IT1249684B (it) 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
EP0635004B1 (en) * 1992-04-10 2002-07-17 Merrell Pharmaceuticals Inc. 4-diphenylmethyl piperidine derivatives and process for their preparation
ES2261871T3 (es) 1993-06-24 2006-11-16 Amr Technology, Inc. Procedimiento para preparar compuestos utiles como intermediarios.

Also Published As

Publication number Publication date
JP4344230B2 (ja) 2009-10-14
CN1516689A (zh) 2004-07-28
US6743941B2 (en) 2004-06-01
DK1401816T3 (da) 2008-06-09
AU2002320847B2 (en) 2007-09-20
HK1063795A1 (en) 2005-01-14
IL159304A (en) 2010-02-17
PL364369A1 (en) 2004-12-13
US20030105329A1 (en) 2003-06-05
WO2002102776A1 (en) 2002-12-27
MXPA03010960A (es) 2004-02-27
CA2450313A1 (en) 2002-12-27
ZA200308697B (en) 2004-09-03
KR100903285B1 (ko) 2009-06-17
EP1401816A1 (en) 2004-03-31
HUP0401125A2 (hu) 2004-09-28
JP2005502603A (ja) 2005-01-27
ATE386021T1 (de) 2008-03-15
BR0210410A (pt) 2004-08-17
PT1401816E (pt) 2008-04-08
DE60225008T2 (de) 2009-01-29
NO20035572D0 (no) 2003-12-12
CN1229347C (zh) 2005-11-30
EP1401816B1 (en) 2008-02-13
NZ530153A (en) 2005-07-29
IL159304A0 (en) 2004-06-01
KR20040010720A (ko) 2004-01-31
CA2450313C (en) 2010-08-10
US7235665B2 (en) 2007-06-26
ES2298384T3 (es) 2008-05-16
AR037005A1 (es) 2004-10-20
DE60225008D1 (de) 2008-03-27
US20040198983A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
ATE507201T1 (de) Energiegünstiges carbonylierungsverfahren
HK1072251A1 (en) Piperidine derivative
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS5715A (is) Aðferð til smíði á 4-karboxýamínó-2-setnu-1,2,3,4-tetrahýdrókínólíni
IS6487A (is) Aðferð til framleiðslu á Sítalóprami
IS7834A (is) Aðferð til nýmyndunar á bensímídasólefnasambandi
ID28724A (id) Proses untuk memproduksi sikloalkanon
IS7239A (is) Aðferð til framleiðslu á essítalóprami
NO20035572L (no) Fremgangsmate til fremstilling av piperidinderivatet fexofenadin
IS7153A (is) Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
FI20011889A0 (fi) Menetelmä ksylitolin valmistamiseksi
DK1362040T3 (da) Fremgangsmåde til fremstilling af mesylater af piperidinderivater
NO20041850L (no) Fremgangsmate for dannelse av profenkrystaller
ID29787A (id) Proses untuk memproduksi cairan kaya-metana
MXPA03009806A (es) Derivados de piperazino y su uso como inhibidor de fosfodiesterasa de nucleotido ciclico de tipo 4 (pde4).
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
NO20001134D0 (no) FremgangsmÕte for fremstilling av VCM
NO20043760L (no) Fremgangsmate til fremstilling av olefiner
ID30126A (id) METODE UNTUK MENGHASILKAN SIKLO-(Asp-DPhe-NMeVal-Arg-Gly)
FI20011563A (fi) Järjestely tuotantolaitosta varten
EE200300204A (et) Meetod distamütsiini derivaadi valmistamiseks
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin
NO20040485L (no) Fremgangsmåte til fremstilling av amorf form av torsemid.
IS5212A (is) Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu
DE10394362D2 (de) Method for the operation of a technical system